Business Context and Reporting Period
Company: CompoSecure, Inc. (Note: Input metadata referenced "GPGI, Inc." but the filing text identifies the registrant as CompoSecure, Inc.)
Reporting Date: January 14, 2026
Event: Completion of a refinancing transaction following the combination with Husky Technologies Limited (completed January 13, 2026). The Company refinanced approximately $2.1 billion of aggregate indebtedness.
Key Financial Metrics and Capital Structure
The filing details a significant restructuring of the Company's debt profile. No revenue, profit, or operating cash flow metrics are provided in this Current Report.
| Instrument | Amount | Key Terms |
|---|---|---|
| 2033 Senior Secured Notes | $900.0 million | 5.625% fixed rate; matures Feb 1, 2033 |
| Term Loan Facility | $1.2 billion | Variable rate (SOFR + 2.25%); matures 2033 |
| Revolving Credit Facility | $400.0 million | Variable rate; matures 2031; $75M available for letters of credit |
| Total New Financing | $2.5 billion | Used to refinance ~$2.1B existing debt and pay fees |
Material Changes vs. Prior Period
- Debt Refinancing: The Company terminated the "Existing Credit Agreement" and repaid all outstanding obligations under it. No early termination penalties were incurred.
- Note Redemption: On January 13, 2026, Husky redeemed all $1.00 billion of its 9.000% Senior Secured Notes for approximately $1.04 billion (including fees and accrued interest).
- Interest Rate Impact: Replaced higher-cost legacy debt (e.g., 9.000% notes) with new senior secured notes at 5.625% and variable rate term loans.
Guidance, Covenants, and Risks
Covenants: The new Indenture and Credit Agreement impose limitations on incurring additional debt, liens, dividends, investments, and asset sales. A "change of control" triggers a mandatory repurchase offer at 101% of principal plus accrued interest.
Financial Covenants: The Revolving Credit Facility includes a springing financial covenant requiring a consolidated first lien net leverage ratio not to exceed a maximum threshold. This covenant is tested quarterly starting September 30, 2026, but only applies if revolving loans and letters of credit exceed 35% of the committed amount.
Incremental Capacity: The Company has an uncommitted incremental facility available subject to leverage ratio tests (e.g., pro forma first lien net leverage ratio ≤ 3.70).
Redemption Options: The 2033 Notes may be redeemed prior to February 1, 2029, at a "make-whole" premium. Up to 40% may be redeemed with equity proceeds at 105.625% prior to that date.
Investor Verification Checklist
- Verify the exact amount of cash proceeds utilized from the new facilities versus existing borrowings to refinance the $2.1 billion legacy debt.
- Confirm the Company's current consolidated first lien net leverage ratio to assess proximity to the springing covenant threshold (35% utilization of revolver).
- Review the full text of the Indenture (Exhibit 4.1) and Credit Agreement (Exhibit 10.1) for specific definitions of "EBITDA" and "Net Leverage Ratio" used in covenant calculations.
- Assess the impact of the new fixed interest rate (5.625%) and variable margins on future interest expense compared to the redeemed 9.000% notes.